Fig. 1From: A novel, accurate, and non-invasive liquid biopsy test to measure cellular immune responses as a tool to diagnose early-stage lung cancer: a clinical trials studyLung cancer type distribution. Distribution of lung cancer types in the cohort of the earlier clinical trial. Subjects were enrolled between 2014-06-02 and 2017-11-16 in three medical centers. The 'Other' group includes lung cancer types other than non-small cells lung cancer and small cells lung cancerBack to article page